Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Vinblastine (1mg) Injection
Therapeutic Category
Anticancer, Oncology
Dosage Form
Injection
Packaging Type
Vial
Packaging
10ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Vinbot 1 Injection contains Vinblastine 1mg, a potent anticancer medication used for the treatment of various malignancies including Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, leukemia, and testicular cancer. It is administered in controlled hospital and oncology settings.
Vinblastine works by inhibiting microtubule formation during mitosis, effectively stopping the division and proliferation of cancer cells. This mechanism plays a critical role in slowing tumor growth and disease progression.
This injection is commonly used as part of combination chemotherapy regimens, allowing oncologists to tailor dosing based on patient response and treatment protocols. Its injectable form ensures precise dosage and reliable bioavailability.
Vinbot 1 Injection contains Vinblastine 1mg, a vinca alkaloid anticancer agent used in chemotherapy. It works by inhibiting microtubule formation in rapidly dividing cells, thereby preventing cancer cell division and slowing tumor growth. The low-dose injectable formulation allows precise dosing and controlled administration in sensitive chemotherapy regimens under strict medical supervision.
Common side effects may include nausea, vomiting, fatigue, hair loss, and mild bone marrow suppression. Serious side effects may include neutropenia, increased risk of infections, peripheral neuropathy, and allergic reactions. Regular monitoring of blood counts is advised during treatment.
Vinbot 1 Injection is indicated for the treatment of various malignancies including Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, testicular cancer, breast cancer, and other cancers as determined by an oncologist. It is often used as part of combination chemotherapy protocols.
Vinbot 1 Injection must be administered only by trained healthcare professionals in a specialized clinical or hospital setting. Dosage should be carefully calculated based on patient condition. Patients should immediately report fever, unusual bleeding, or signs of infection to their doctor.
Store Vinbot 1 Injection in a cool, dry place, protected from light. Keep the vial tightly closed and out of reach of children. Do not use if the solution appears discolored or contains visible particles.
Composition : Triamcinolone 4 mg Tablet
Composition : Methylprednisolone (125mg)
Composition : Methylprednisolone (1000mg) Injection
Composition : Methylprednisolone (40mg)
Composition : Methylprednisolone (500mg)
Composition : Fluticasone Furoate (27.5mcg)
Composition : Fluticasone Furoate (50mcg)
Composition : Fluticasone Propionate (0.005% w/v)
Composition : Xylometazoline (0.05% w/v)
Composition : Budesonide (0.5mg) Respule
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Vinbot 1 Injection has demand in the oncology and critical-care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on cancer-care and specialty medicine portfolios.
Medical distributors and agencies can benefit from demand for management of certain cancers such as Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, testicular cancer, breast cancer, and other oncology-related conditions. Vinblastine 1mg is an anti-cancer chemotherapy medicine that helps slow or stop the growth of cancer cells The injectable formulation supports hospital-based and oncology treatment protocols This strengthens a reliable oncology and specialty-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Vinbot 1 Injection with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from hospital and oncologist demand, specialty-care market opportunities, institutional supply requirements, reliable supply chain support, and good margins in oncology medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.